WO2018210973A1 - Peritonealdialysegerät - Google Patents

Peritonealdialysegerät Download PDF

Info

Publication number
WO2018210973A1
WO2018210973A1 PCT/EP2018/062816 EP2018062816W WO2018210973A1 WO 2018210973 A1 WO2018210973 A1 WO 2018210973A1 EP 2018062816 W EP2018062816 W EP 2018062816W WO 2018210973 A1 WO2018210973 A1 WO 2018210973A1
Authority
WO
WIPO (PCT)
Prior art keywords
patient
peritoneal dialysis
control unit
phase
inlet
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2018/062816
Other languages
German (de)
English (en)
French (fr)
Inventor
Klaus Wolf
Peter Wabel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fresenius Medical Care Deutschland GmbH
Original Assignee
Fresenius Medical Care Deutschland GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fresenius Medical Care Deutschland GmbH filed Critical Fresenius Medical Care Deutschland GmbH
Priority to EP18728540.8A priority Critical patent/EP3624872B1/de
Priority to JP2019563475A priority patent/JP2020520272A/ja
Priority to CN202511981055.XA priority patent/CN121570674A/zh
Priority to CN201880031992.0A priority patent/CN110621362A/zh
Priority to US16/613,437 priority patent/US11369723B2/en
Publication of WO2018210973A1 publication Critical patent/WO2018210973A1/de
Anticipated expiration legal-status Critical
Priority to JP2024067258A priority patent/JP7724326B2/ja
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/28Peritoneal dialysis ; Other peritoneal treatment, e.g. oxygenation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/28Peritoneal dialysis ; Other peritoneal treatment, e.g. oxygenation
    • A61M1/287Dialysates therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/18General characteristics of the apparatus with alarm
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/33Controlling, regulating or measuring
    • A61M2205/3331Pressure; Flow
    • A61M2205/3334Measuring or controlling the flow rate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/70General characteristics of the apparatus with testing or calibration facilities

Definitions

  • the invention relates to a device for performing a peritoneal dialysis treatment on a patient.
  • Peritoneal dialysis is also known as peritoneal dialysis.
  • PD techniques including automated peritoneal dialysis (APO) procedures using peritoneal dialysis machines.
  • APO automated peritoneal dialysis
  • all or at least some of the treatment steps are automated. This can be, for example, the switching on or off of pumps, the opening or closing of valves, etc.
  • the effect of causing a flow of dialysis solution may be gravimetric, i. by gravity, and / or by means of one or more pumps.
  • the present invention is not limited to any particular type of PD, ie, includes both automatic, non-automatic, gravimetric, and pump-powered devices.
  • the device leads the patient, for example, automatically through a pump or gravimetrically in a run-in phase via a catheter, a dialysis solution into the abdominal cavity.
  • the dialysis solution is then left in the abdominal cavity during a holding period.
  • small molecular substances from the blood on the capillaries of the peritoneum can pass into the dialysis solution, as there is a concentration gradient, also the body can be removed in this way, water, if the dialysis solution has a higher content of osmotically active substances than the blood.
  • the device removes the dialysis solution enriched with excreted substances and thus consumed again in a discharge phase via the catheter from the abdominal cavity.
  • the liquid exchange can be done gravimetrically or actively by means of a pump.
  • a new break-in phase is started whenever the device determines that the drainage phase has ended, that is, that the spent dialysis fluid has completely or partially drained from the abdominal cavity of the patient.
  • Dialysis solution is as completely as possible removed from the abdominal cavity to ensure the largest possible exchange volumes.
  • the object of the invention is to provide a peritoneal dialysis device with which the progress of the process or the actual end of the process phase can be detected more reliably.
  • the invention relates to a peritoneal dialysis machine, preferably for carrying out an automated peritoneal dialysis treatment with repetitive cycles, the cycles comprising an inlet phase, a holding period and a drainage phase for the dialysis fluid, wherein the device comprises a control unit and a measuring device for determining the inlet and / or discharge rate of the dialysis fluid from a patient.
  • control unit is designed to make a comparison between a time curve of the inlet and / or outflow rate determined by the measuring device during a run-in and / or run-down phase with a corresponding reference curve and, based on this comparison, a fault in the run-in and / or expiry of the dialysis fluid to or from the patient.
  • the device is designed such that the inlet and the drain are automated by means of a control unit of the device.
  • a reference curve for the time profile of the outflow rate during the run-in and / or run-down phase is stored in the control unit, with which a measured comparison curve is compared.
  • an atypical time profile of the inlet and / or outflow rate can be detected, which indicates a disturbance in the inlet and / or outlet phase.
  • the recognition accuracy can be improved, whether really the whole or the desired amount of the dialysis fluid has expired from the patient.
  • countermeasures can be initiated in the event of a fault.
  • the present invention preferably relates to actively-promoting EPO devices, i. Peritoneal dialysis machines in which the inlet and / or the drainage of the dialysis solution in / from the patient by means of one or more pumps, as well as gravimetrically operating peritoneal dialysis machines, in which said inlet and / or outlet by means of gravity and without pumps erfoigt.
  • the control of the fluid flows in both cases is preferably automated, e.g. by opening and closing valves etc.
  • control unit is designed so that upon detection of a disturbance in the course of the dialysis fluid from the patient, a time-limited observation phase is started, during which of the
  • Outflow rate is measured and checked for the Wiedererich a Minimelfiusses. It is thus waited in this embodiment, whether again adjusts an iVlinimaifiuss, for example, because a kink in the catheter or in the hose dissolves by movement of the patient by itself again. If, during the observation phase, which can last, for example, between 1 and 5 minutes, the aspired IVlinimaifiuss not reached again, further measures can be provided.
  • the iVlinimaifiuss for example, correspond to the flow that would be provided in the reference curve at a certain time of the Abiaufphase, possibly corrected by a tolerance deduction.
  • control unit is designed such that upon detection of a disturbance in the course of the dialysis fluid from the patient, a volume is conveyed in the direction of the patient. Based on this measure, the quality of the line can be checked. The promotion can for example be done actively by means of a fluid pump. The measure may, if appropriate, be taken after the end of an observation phase, if such is provided for. In one embodiment, it is provided that the control unit is designed so that upon detection of a fault in the inlet and / or outlet of the dialysis fluid to or from the patient a Signa! is issued.
  • the device has a signal unit or an interface for communication with an external signal unit.
  • the signal output may be an attempt to improve the situation.
  • the signal may be used to wake or stimulate the patient, or to alert them to move or actively re-start the catheter.
  • Suitable signals include, for example, optical signals, audio signals or vibration signals.
  • the measure may optionally be taken after the expiry of an observation phase and / or after a volume has been conveyed in the direction of the patient, provided that such measures are provided, in one embodiment it is provided that the control unit is designed such that on the basis of the comparison an optimization of the Device configuration is made.
  • criteria as to when a sequence phase should be regarded as terminated can be adapted to a patient in accordance with the reference curve and the measured curve.
  • the reference curve is a patient-independent function that is stored in the control unit.
  • the reference curve can, for example, schematically parameters based on prescribing, such as the 'amount of the administered fluid, are defined.
  • the reference curve is a patient-specific function.
  • a reference curve is recorded in a setting cycle before the start of treatment.
  • the reference curve ve is determined from a plurality of measured curves, for example by averaging.
  • the reference curve may be formed by a superposition of curves measured in a certain number of previous cycles or treatments, so it may be a patient-specific mean.
  • the device is a gravimetrically operating device.
  • one or more valves may be provided and the controller may be configured to open the or a valve after the hold phase and before the start of the drain phase to allow gravimetric drainage of dialysis fluid from the patient and / or the valve or valves the drain phase and before the start of the run-in phase is opened to allow a gravimetric inlet of dialysis fluid to the patient.
  • the device is an actively conveying device.
  • one or more pumps may be provided, and the control unit may be designed to withdraw dialysis fluid from the patient during the drainage phase and / or to supply dialysis fluid to the patient during or by means of the pump.
  • the invention comprises a method for performing a peritoneal dialysis using a peritoneal dialysis apparatus according to the invention, wherein a comparison between a measured time course curve of the inlet and / or outflow rate during an inlet and / or Abiaufphase is made with a corresponding reference curve, and wherein on Basis of this comparison is a disturbance in the inlet and / or outlet of the dialysis fluid to or recognized by the patient.
  • Advantageous embodiments of the method will become apparent from the above description of the configuration of the control unit in per se invention perigeeadiavsencing Further details and advantages of the invention will become apparent from the following explained with reference to the figure embodiment.
  • the single figure shows possible temporal courses of the outflow rate (volume / time) in the abdominal cavity during the expiration phase with gravimetric, ie, passive Abiauf.
  • a peritoneal dialysis machine intended for performing automated peri-oral dialysis treatment with repetitive cycles comprising an inflow phase, a hold period, and a dialysis fluid drainage phase.
  • the device comprises a control unit and a measuring device for determining the inflow and / or outflow rate of the dialysis fluid from a patient. It further comprises a dialysis pump for delivering dialysis fluid to the patient, and a drain valve which is opened by the control unit after the holding phase and before the start of the expiration phase to allow a gravimetric discharge of dialysis fluid from the patient.
  • the control unit is a reference curve for the timing of the phase-out phase deposited, which is patient-individual and was formed by a superposition of curves that were used as part of operations in a certain number of previous cycles.
  • an algorithm is stored on the control unit, by means of which a comparison between a time profile curve of the outflow rate determined by the measuring device during a further execution phase with the reference curve can be made. The algorithm also makes it possible to detect, on the basis of this comparison, a malfunction in the course of the dialysis fluid from the patient.
  • the memory may also be on a moving object, such as on a patient card or any other memory that does not form part of the device. If a fault is detected, the control unit is designed to take a number of measures.
  • a certain, for example, three-minute, observation phase is started, in which the outflow rate is continuously measured and checked for the re-achievement of a minimum flow.
  • the minimum affinity corresponds to the flow that should be present before the occurrence of the disturbance, minus a specific, for example 30%, tolerance interval.
  • control unit blocks the dialysate pump in order to convey a specific, smaller volume of, for example, 100 ml in the direction of the patient. Based on this measure, the quality of the line can be checked.
  • a warning signal preferably acoustic information, may be output.
  • control unit gives an audible signal to a signal unit installed in the device. out. It should be able to wake the patient and alert them to change his position.
  • the signaling can be repeated in the same or more intensive form that the patient may actually stand up to check the function of the lines.
  • the curve "reference" of the figure shows a temporal progression of the outflow rate in a device according to the exemplary embodiment in the normative case The outflow rate decreases due to the increasing emptying of the patient due to the decreasing hydrostatic pressure.
  • the "fault 1" curve of the figure shows a time course of the drainage rate in the event that the drain is disturbed shortly before the end of the run-away phase, for example, if the drainage catheter sags or is otherwise plugged or pinched / pinched , so that the further process stops when a certain hydrostatic pressure is exceeded.
  • fault 2 shows a time course of the outflow rate in the event that the drain is disturbed a little earlier, for example, when the drainage catheter is kinked or otherwise blocked by a patient's motion during sleep , such as is clogged, so that the further process does not continue when falling below a certain hydrostatic pressure.
  • Advantages of the solution according to the invention include, for example, an avoidance of premature switching from a phase-out phase into the inrush phase of the subsequent cycle, as well as an overall improvement in the behavior and hence an optimization of the therapy.
  • the number of unauthorized or unintentionally terminated phasing out periods can be reduced.
  • the patient receives improved feedback, for example with regard to his sleeping position, the bed height or the location of the device.

Landscapes

  • Health & Medical Sciences (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • External Artificial Organs (AREA)
PCT/EP2018/062816 2017-05-16 2018-05-16 Peritonealdialysegerät Ceased WO2018210973A1 (de)

Priority Applications (6)

Application Number Priority Date Filing Date Title
EP18728540.8A EP3624872B1 (de) 2017-05-16 2018-05-16 Peritonealdialysegerät
JP2019563475A JP2020520272A (ja) 2017-05-16 2018-05-16 腹膜透析機械
CN202511981055.XA CN121570674A (zh) 2017-05-16 2018-05-16 腹膜透析设备
CN201880031992.0A CN110621362A (zh) 2017-05-16 2018-05-16 腹膜透析设备
US16/613,437 US11369723B2 (en) 2017-05-16 2018-05-16 Peritoneal dialysis machine
JP2024067258A JP7724326B2 (ja) 2017-05-16 2024-04-18 腹膜透析機械

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102017110607.3A DE102017110607A1 (de) 2017-05-16 2017-05-16 Peritonealdialysegerät
DE102017110607.3 2017-05-16

Publications (1)

Publication Number Publication Date
WO2018210973A1 true WO2018210973A1 (de) 2018-11-22

Family

ID=62492591

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2018/062816 Ceased WO2018210973A1 (de) 2017-05-16 2018-05-16 Peritonealdialysegerät

Country Status (6)

Country Link
US (1) US11369723B2 (enExample)
EP (1) EP3624872B1 (enExample)
JP (2) JP2020520272A (enExample)
CN (2) CN121570674A (enExample)
DE (1) DE102017110607A1 (enExample)
WO (1) WO2018210973A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN121215211B (zh) * 2025-11-27 2026-03-03 中国人民解放军陆军军医大学第二附属医院 一种血液透析数据的智能扰动与分析方法和系统

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090012455A1 (en) * 2007-07-05 2009-01-08 Baxter International Inc. Dialysis system having supply container autoconnection
WO2013141896A1 (en) * 2012-03-23 2013-09-26 Nxstage Medical, Inc. Peritoneal dialysis systems, devices, and methods

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1691863B1 (en) * 2003-10-13 2008-02-20 Gambro Lundia AB A device for carrying out a peritoneal dialysis treatment
JPWO2007114447A1 (ja) * 2006-04-06 2009-08-20 株式会社根本杏林堂 薬液注入装置
US8521482B2 (en) * 2009-02-20 2013-08-27 Baxter International Inc. Simulation of patient drain phase in peritoneal dialysis
US20110141116A1 (en) * 2009-12-16 2011-06-16 Baxter International Inc. Methods and apparatus for displaying flow rate graphs and alarms on a dialysis system
CN103153359B (zh) * 2009-12-24 2015-12-02 昆山韦睿医疗科技有限公司 自动腹膜透析循环系统及其应用
US9861733B2 (en) * 2012-03-23 2018-01-09 Nxstage Medical Inc. Peritoneal dialysis systems, devices, and methods
CN103619372A (zh) * 2011-03-23 2014-03-05 纳科斯达格医药股份有限公司 腹膜透析系统、装置和方法
DE102014005122A1 (de) * 2014-04-08 2015-10-08 Fresenius Medical Care Deutschland Gmbh Verfahren zur Abschätzung der Behandlungsdauer einer Pertionealdialyse-Behandlung
EP3151877B1 (en) * 2014-06-05 2020-04-15 DEKA Products Limited Partnership System for calculating a change in fluid volume in a pumping chamber

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090012455A1 (en) * 2007-07-05 2009-01-08 Baxter International Inc. Dialysis system having supply container autoconnection
WO2013141896A1 (en) * 2012-03-23 2013-09-26 Nxstage Medical, Inc. Peritoneal dialysis systems, devices, and methods

Also Published As

Publication number Publication date
JP2020520272A (ja) 2020-07-09
CN121570674A (zh) 2026-02-27
JP2024097791A (ja) 2024-07-19
US11369723B2 (en) 2022-06-28
DE102017110607A1 (de) 2018-11-22
JP7724326B2 (ja) 2025-08-15
CN110621362A (zh) 2019-12-27
US20200164130A1 (en) 2020-05-28
EP3624872B1 (de) 2025-02-19
EP3624872A1 (de) 2020-03-25

Similar Documents

Publication Publication Date Title
EP3049125B1 (de) Sensorik zur detektion von phasen und/oder phasenübergängen bei peritonealdialysebehandlungen
EP2736554B1 (de) Verfahren zum entfernen von fluid aus einem blutfilter nach beendigung einer blutbehandlungssitzung und behandlungsvorrichtung zum durchführen desselben
EP3177338B1 (de) Verfahren zum auswaschen von gasblasen in einem extrakorporalen blutkreislauf
EP2913073B1 (de) Vorrichtung zur Erkennung einer venösen Nadeldiskonnektion
EP2200675A1 (de) Verfahren zum erfassen der ionenkonzentration bei citrat-antikoagulierter extrakorporaler blutreinigung
DE102014109136A1 (de) Verfahren zum Entfernen von Fluid aus einem Blutfilter nach Beendigung einer Blutbehandlungssitzung mittels Flusserhöhung und Behandlungsvorrichtung zum Durchführen desselben
DE102016117725A1 (de) Verfahren zum Entfernen von Blut aus einem extrakorporalen Blutkreislauf nach Beendigung einer Blutbehandlungssitzung, Steuerungs- und Regelungseinrichtung sowie Behandlungsvorrichtung zum Durchführen desselben
DE102011108777A9 (de) Verfahren zum Entfernen von Blut aus einem extrakorporalen Blutkreislauf sowie Vorrichtungen
EP3820542B1 (de) Steuerungs- und/oder regelungseinrichtung zum entfernen von fluid aus einem blutfilter
EP3177339B1 (de) Verfahren zum spülen eines extrakorporalen blutkreislaufs
DE102009024606A1 (de) Verfahren zum Entfernen von Blut aus einem extrakorporalen Blutkreislauf, Behandlungsvorrichtung sowie Schlauchsystem
EP3624872B1 (de) Peritonealdialysegerät
EP3131603B1 (de) Vorrichtung zum entfernen von blut aus einem extrakorporalen blutkreislauf unter druckkontrolle
EP3206732B1 (de) Vorrichtung zur ereignisabhängigen grenzwertüberwachung einer dialysemaschine
DE102013011010A1 (de) Verfahren und Vorrichtung zur Turbulenzerzeugung durch pulsierenden Fluss
WO2021164989A1 (de) Fluidflusssteuerung einer blutbehandlungsvorrichtung
EP3237036B1 (de) Infusionsleitung mit einrichtung zum begünstigen einer vermischung einer infusionslösung mit einem weiteren fluid
EP3129081B1 (de) Dialysegerät zur abschätzung der behandlungsdauer einer peritonealdialyse-behandlung
EP3624871A1 (de) Peritonealdialysegerät
DE102016101648A1 (de) Verfahren zum Regeln einer Heizvorrichtung zum Erwärmen eines Fluids für einen Dialysierflüssigkeitskreislauf, Steuervorrichtung sowie Blutbehandlungsvorrichtung
WO2025176714A1 (de) Verfahren zum überprüfen eines bestückungszustandes einer blutbehandlungsvorrichtung, und vorrichtungen
WO2016041798A1 (de) Verfahren und vorrichtung zur steuerung der behandlungsdauer von behandlungen mit medizintechnischen geräten

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 18728540

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2019563475

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 2018728540

Country of ref document: EP

Effective date: 20191216